Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Pozzilli

Showing results (181-190 of 225) with videos related to

Pageof 23
Sort By:
Diabetes|December 25, 2003
C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001Jerry P Palmer, G Alexander Fleming, Carla J Greenbaum, et al.
Bone|May 7, 2019
Risk factors for fragility fractures in type 1 diabetesGiulia Leanza, Ernesto Maddaloni, Dario Pitocco, et al.
The Journal of Clinical Endocrinology and Metabolism|August 16, 2016
PTH(1-34) for the Primary Prevention of Postthyroidectomy Hypocalcemia: The THYPOS TrialAndrea Palermo, Giuseppe Mangiameli, Gaia Tabacco, et al.
Diabetes, Obesity & Metabolism|May 19, 2022
Ladarixin, an inhibitor of the interleukin-8 receptors CXCR1 and CXCR2, in new-onset type 1 diabetes: A multicentre, randomized, double-blind, placebo-controlled trialLorenzo Piemonti, Bart Keymeulen, Pieter Gillard, et al.
Diabetes Technology & Therapeutics|January 8, 2004
A 2-year pilot trial of continuous subcutaneous insulin infusion versus intensive insulin therapy in patients with newly diagnosed type 1 diabetes (IMDIAB 8)Paolo Pozzilli, Antonino Crinò, Riccardo Schiaffini, et al.
The Journal of Clinical Endocrinology and Metabolism|March 6, 2018
Serum Sclerostin and Bone Turnover in Latent Autoimmune Diabetes in AdultsNicola Napoli, Rocky Strollo, Giuseppe Defeudis, et al.
Diabetes/Metabolism Research and Reviews|July 26, 2016
Autoantibodies to post-translationally modified type I and II collagen in Charcot neuroarthropathy in subjects with type 2 diabetes mellitusPaola Rizzo, Dario Pitocco, Francesco Zaccardi, et al.
Diabetes|June 23, 2010
Age-period-cohort analysis of 1990-2003 incidence time trends of childhood diabetes in Italy: the RIDI studyGraziella Bruno, Milena Maule, Franco Merletti, et al.
Diabetes Research and Clinical Practice|September 24, 2020
Clinical features of patients with type 2 diabetes with and without Covid-19: A case control study (CoViDiab I)Ernesto Maddaloni, Luca D'Onofrio, Francesco Alessandri, et al.
BMJ Open Diabetes Research & Care|April 9, 2015
The effect of macrobiotic Ma-Pi 2 diet on systemic inflammation in patients with type 2 diabetes: a post hoc analysis of the MADIAB trialAndreea Soare, Rossella Del Toro, Elena Roncella, et al.
Pageof 23

Showing results (181-190 of 225) with videos related to

Sort By:
Pageof 23
Diabetes|December 25, 2003
C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001Jerry P Palmer, G Alexander Fleming, Carla J Greenbaum, et al.
Bone|May 7, 2019
Risk factors for fragility fractures in type 1 diabetesGiulia Leanza, Ernesto Maddaloni, Dario Pitocco, et al.
The Journal of Clinical Endocrinology and Metabolism|August 16, 2016
PTH(1-34) for the Primary Prevention of Postthyroidectomy Hypocalcemia: The THYPOS TrialAndrea Palermo, Giuseppe Mangiameli, Gaia Tabacco, et al.
Diabetes, Obesity & Metabolism|May 19, 2022
Ladarixin, an inhibitor of the interleukin-8 receptors CXCR1 and CXCR2, in new-onset type 1 diabetes: A multicentre, randomized, double-blind, placebo-controlled trialLorenzo Piemonti, Bart Keymeulen, Pieter Gillard, et al.
Diabetes Technology & Therapeutics|January 8, 2004
A 2-year pilot trial of continuous subcutaneous insulin infusion versus intensive insulin therapy in patients with newly diagnosed type 1 diabetes (IMDIAB 8)Paolo Pozzilli, Antonino Crinò, Riccardo Schiaffini, et al.
The Journal of Clinical Endocrinology and Metabolism|March 6, 2018
Serum Sclerostin and Bone Turnover in Latent Autoimmune Diabetes in AdultsNicola Napoli, Rocky Strollo, Giuseppe Defeudis, et al.
Diabetes/Metabolism Research and Reviews|July 26, 2016
Autoantibodies to post-translationally modified type I and II collagen in Charcot neuroarthropathy in subjects with type 2 diabetes mellitusPaola Rizzo, Dario Pitocco, Francesco Zaccardi, et al.
Diabetes|June 23, 2010
Age-period-cohort analysis of 1990-2003 incidence time trends of childhood diabetes in Italy: the RIDI studyGraziella Bruno, Milena Maule, Franco Merletti, et al.
Diabetes Research and Clinical Practice|September 24, 2020
Clinical features of patients with type 2 diabetes with and without Covid-19: A case control study (CoViDiab I)Ernesto Maddaloni, Luca D'Onofrio, Francesco Alessandri, et al.
BMJ Open Diabetes Research & Care|April 9, 2015
The effect of macrobiotic Ma-Pi 2 diet on systemic inflammation in patients with type 2 diabetes: a post hoc analysis of the MADIAB trialAndreea Soare, Rossella Del Toro, Elena Roncella, et al.
Pageof 23